Acorda Therapeutics

ACOR

23.45

-0.15

-0.6%

After Hours:

23.45

0.00

0.0%

Please Login or Register

Login|Register FREE

Stock Price
Open: 23.55
Prev. Close: 23.60
Low/Hi: 23.15 - 23.70
52-Week: 13.60 - 33.00
Volumes
Equity: 316,683
90-Day Avg: 864,507
Option: 63
90-Day Avg: 264
Volatility
Todays Stock Vol: 22.6
20-Day (HV): 57.1
52-Week (HV): 55.6
30-Day IV: 53.5 -0.5
IV Pct Rank: 38% Subdued
Fundamental
Div. Yield: 0.0%
Earnings: 25-Oct (Est.)
P/E Ratio:
Market Cap: 1.1 B
Stock Type: Common
Sector: Healthcare
Industry: Biotechnology
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

ACOR Cash Flow

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Jun-2017 31-Mar-2017 31-Dec-2016 30-Sep-2016
Net Income 13,666 -18,904 -3,094 -12,725
Change in Working Capital -13,829 -28,970 21,534 -3,951
Depreciation Amortization Depletion and Accretion 9,861 8,227 -1,818 8,453
Deferred Taxes 3,055 -4,673 -668 594
Other Non-Cash Activities 19,428 18,919 7,548 13,660
Total Cash from Operating Activities 10,320 -25,401 32,475 5,725
Capital Expenditures -3,105 -5,849 -1,970 -2,223
Other Investing Cash Flow 0 0 1,654 0
Total Cash from Investing Activities -3,105 -5,849 -316 -2,223
Dividends and Distributions 0 0 -27,946 14,489
Purchase or Sale of Stock -60 5,474 847 622
Purchase and Retirement of Debt -184 -2,225 0 0
Other Financing Cash Flow 0 2,722 27,918 -28,026
Total Cash from Financing Activities -244 5,971 804 -12,915
Exchange Rate Effects 545 361 -2,366 -47
Net Change in Cash 7,516 -24,918 30,597 -9,460
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Net Income -34,618 11,058 17,672 16,441
Change in Working Capital 15,229 -25,494 -4,176 -21,117
Depreciation Amortization Depletion and Accretion 31,766 26,955 16,362 9,575
Deferred Taxes -11,190 3,975 6,681 9,520
Other Non-Cash Activities 35,145 21,987 38,481 24,866
Total Cash from Operating Activities 35,347 38,481 75,020 39,285
Capital Expenditures -7,085 -7,066 -7,783 -7,164
Other Investing Cash Flow -66,701 -78,170 -286,042 -37,928
Total Cash from Investing Activities -73,786 -85,236 -293,825 -45,092
Dividends and Distributions -27,946 0 0 0
Purchase or Sale of Stock 75,520 18,096 16,015 12,786
Purchase and Retirement of Debt -56 -501 344,438 -909
Other Financing Cash Flow -1,587 194 -7,516 91
Total Cash from Financing Activities 45,931 17,789 352,937 11,968
Exchange Rate Effects -2,159 0 0 0
Net Change in Cash 5,333 -28,966 134,132 6,161